Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Letter to House Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
Letter to Senate Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Sign-on Letter Supporting the Telehealth Expansion Act
-
Sign-on Letter Supporting the Saving Access to Laboratory Services Act
-
Sign-on Letter Opposing Updated VALID Act & ACM Exemption
-
Sign-on Letter Urging Extension of Telehealth Flexibilities
-
Sign-on Letter to Congressional Leadership Concerning the VALID Act